Viridian Therapeutics, Inc.\DE annual gross margin
2013
2014
2015
2016
Viridian Therapeutics, Inc.\DE Gross Margin Growth & History (VRDN)
Viridian Therapeutics, Inc.\DE's gross margin was 26.72% for fiscal 2016.
View full Viridian Therapeutics, Inc.\DE company overviewViridian Therapeutics, Inc.\DE annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2016 | 2016-12-31 | 26.72% | −29.96 pp |
| 2015 | 2015-12-31 | 56.68% | +8.59 pp |
| 2014 | 2014-12-31 | 48.09% | −1.32 pp |
| 2013 | 2013-12-31 | 49.41% | — |
Viridian Therapeutics, Inc.\DE quarterly gross margin
Q2.13
Q3.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q4 2016 | 2016-12-31 | −453.83% | −525.21 pp |
| Q3 2016 | 2016-09-30 | 36.00% | −20.77 pp |
| Q2 2016 | 2016-06-30 | 70.22% | +16.76 pp |
| Q1 2016 | 2016-03-31 | 69.32% | +27.02 pp |
| Q4 2015 | 2015-12-31 | 71.38% | +23.21 pp |
| Q3 2015 | 2015-09-30 | 56.78% | +4.86 pp |
| Q2 2015 | 2015-06-30 | 53.47% | +12.32 pp |
| Q1 2015 | 2015-03-31 | 42.29% | −8.45 pp |
| Q4 2014 | 2014-12-31 | 48.18% | — |
| Q3 2014 | 2014-09-30 | 51.92% | +1.58 pp |
| Q2 2014 | 2014-06-30 | 41.15% | −10.18 pp |
| Q1 2014 | 2014-03-31 | 50.74% | — |
| Q3 2013 | 2013-09-30 | 50.35% | — |
| Q2 2013 | 2013-06-30 | 51.33% | — |
Viridian Therapeutics, Inc.\DE gross margin trends
Between the periods ended 2013-12-31 and 2016-12-31, Viridian Therapeutics, Inc.\DE's gross margin decreased from 49.41% to 26.72%, a change of −22.69 percentage points. The latest reported quarter, Q4 2016, shows −453.83%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Viridian Therapeutics, Inc.\DE source filings ↗